Literature DB >> 7521845

Vitronectin in colorectal adenocarcinoma--synthesis by stromal cells in culture.

B R Tomasini-Johansson1, C Sundberg, G Lindmark, J O Gailit, K Rubin.   

Abstract

We have investigated the expression and cellular source of vitronectin in colorectal adenocarcinoma. Immunofluorescence staining of tissue sections revealed the presence of vitronectin in the stroma of the 11 tumors studied, but not in adjacent normal colon. A method was devised for the isolation from colorectal adenocarcinomas of fibroblast-like cells that stained positive for vimentin but negative for cytokeratin. These tumor-derived stromal cells synthesized and secreted vitronectin, as revealed by metabolic labeling and immunoprecipitation. This was confirmed by Southern blot analysis of polymerase chain reaction amplification products from reverse-transcribed RNA. Normal skin fibroblasts did not synthesize vitronectin. Immunofluorescence staining showed vitronectin deposited at focal contact sites in the tumor-derived cells, where it colocalized with vinculin and the alpha v integrin subunit. The deposition of vitronectin into focal contact sites was not dependent on the presence of serum. The finding that vitronectin can be synthesized and secreted by tumor-derived fibroblast-like cells in culture indicates that vitronectin expression can be promoted by as yet unknown signals provided in disease states, such as cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7521845     DOI: 10.1006/excr.1994.1262

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

1.  Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress.

Authors:  E Sivridis; A Giatromanolaki; M I Koukourakis
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

2.  Vitronectin significantly influences prognosis in osteosarcoma.

Authors:  Kai Shi; Rui-Long Lan; Xuan Tao; Chao-Yang Wu; Hai-Feng Hong; Jian-Hua Lin
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  Interaction of late apoptotic and necrotic cells with vitronectin.

Authors:  Ondrej Stepanek; Tomas Brdicka; Pavla Angelisova; Ondrej Horvath; Jiri Spicka; Petr Stockbauer; Petr Man; Vaclav Horejsi
Journal:  PLoS One       Date:  2011-05-04       Impact factor: 3.240

4.  PAI-1: An Integrator of Cell Signaling and Migration.

Authors:  Ralf-Peter Czekay; Cynthia E Wilkins-Port; Stephen P Higgins; Jennifer Freytag; Jessica M Overstreet; R Matthew Klein; Craig E Higgins; Rohan Samarakoon; Paul J Higgins
Journal:  Int J Cell Biol       Date:  2011-08-03

5.  Matrix-bound PAI-1 supports cell blebbing via RhoA/ROCK1 signaling.

Authors:  Amandine Cartier-Michaud; Michel Malo; Cécile Charrière-Bertrand; Gilles Gadea; Christelle Anguille; Ajitha Supiramaniam; Annick Lesne; Franck Delaplace; Guillaume Hutzler; Pierre Roux; Daniel A Lawrence; Georgia Barlovatz-Meimon
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

6.  CD133+ colon cancer cells are more interactive with the tumor microenvironment than CD133- cells.

Authors:  Celia Chao; J Russ Carmical; Kirk L Ives; Thomas G Wood; Judith F Aronson; Guillermo A Gomez; Clarisse D Djukom; Mark R Hellmich
Journal:  Lab Invest       Date:  2011-12-12       Impact factor: 5.662

7.  Molecular determinants of αVβ5 localization in flat clathrin lattices - role of αVβ5 in cell adhesion and proliferation.

Authors:  Alba Zuidema; Wei Wang; Maaike Kreft; Onno B Bleijerveld; Liesbeth Hoekman; Jonas Aretz; Ralph T Böttcher; Reinhard Fässler; Arnoud Sonnenberg
Journal:  J Cell Sci       Date:  2022-06-06       Impact factor: 5.235

8.  A list of candidate cancer biomarkers for targeted proteomics.

Authors:  Malu Polanski; N Leigh Anderson
Journal:  Biomark Insights       Date:  2007-02-07

9.  CITED4 gene silencing in colorectal cancer cells modulates adherens/tight junction gene expression and reduces cell proliferation.

Authors:  Michael A Rogers; Verena Kalter; Gemma Marcias; Marc Zapatka; Sebastian Barbus; Peter Lichter
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-05       Impact factor: 4.553

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.